Topic: BioSante Pharmaceuticals Inc.
(Reuters) - BioSante Pharmaceuticals Inc said it signed an option agreement for use of its antibody production technology with an undisclosed pharmaceutical company, sending its shares up as much as 5 percent in Monday morning trade.Details of the option
<div id="subtitle">FDA gives BioSante pancreatic cancer treatment 'orphan drug' designationBioSante Pharmaceuticals has received orphan drug status for its potential pancreatic cancer treatment, the company said Monday.The company said the Food and